T. Rowe Price Associates’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-7,226
| Closed | -$423K | – | 2548 |
|
|
2020
Q1 | $423K | Sell |
7,226
-535
| -7% | -$31.3K | ﹤0.01% | 2056 |
|
|
2019
Q4 | $981K | Sell |
7,761
-351
| -4% | -$44.4K | ﹤0.01% | 1891 |
|
|
2019
Q3 | $993K | Sell |
8,112
-2,959
| -27% | -$362K | ﹤0.01% | 1827 |
|
|
2019
Q2 | $3.31M | Sell |
11,071
-54
| -0.5% | -$16.1K | ﹤0.01% | 1455 |
|
|
2019
Q1 | $5.01M | Buy |
11,125
+19
| +0.2% | +$8.55K | ﹤0.01% | 1398 |
|
|
2018
Q4 | $5.08M | Sell |
11,106
-2
| -0% | -$914 | ﹤0.01% | 1404 |
|
|
2018
Q3 | $10.1M | Sell |
11,108
-5
| -0% | -$4.55K | ﹤0.01% | 1370 |
|
|
2018
Q2 | $6.52M | Sell |
11,113
-20
| -0.2% | -$11.7K | ﹤0.01% | 1407 |
|
|
2018
Q1 | $7.25M | Buy |
+11,133
| New | +$7.25M | ﹤0.01% | 1377 |
|